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Long-chain polyunsaturated fatty acids (LC-PUFA)
and their metabolites are critical players in cell
biology and embryonic development. Here we
show that long-chain acyl-CoA synthetase 4a
(Acsl4a), an LC-PUFA activating enzyme, is essential
for proper patterning of the zebrafish dorsoventral
axis. Loss of Acsl4a results in dorsalized embryos
due to attenuated bone morphogenetic protein
(Bmp) signaling. We demonstrate that Acsl4a modu-
lates the activity of Smad transcription factors, the
downstream mediators of Bmp signaling. Acsl4a
promotes the inhibition of p38 mitogen-activated
protein kinase and the Akt-mediated inhibition of
glycogen synthase kinase 3, critical inhibitors of
Smad activity. Consequently, introduction of a
constitutively active Akt can rescue the dorsalized
phenotype of Acsl4a-deficient embryos. Our results
reveal a critical role for Acsl4a in modulating Bmp-
Smad activity and provide a potential avenue for
LC-PUFAs to influence a variety of developmental
processes.
INTRODUCTION
Fatty acids (FAs) play essential roles in the cell as sources of
energy, membrane components, and signaling molecules. Any
FA can be converted into energy, but long-chain polyunsatu-
rated FAs (LC-PUFAs) such as arachidonic acid (AA), eicosapen-
taenoic acid (EPA), and docosahexaenoic acid also play critical
roles in membrane fluidity and as precursors of signaling mole-
cules such as eicosanoids (Bazan, 2006; Grossfield et al.,
2006; Kitajka et al., 2002; Stillwell et al., 2005). Acyl-CoA synthe-
tase enzymes convert free FAs to fatty acyl-CoAs as the initial
step in a majority of FA processing events. There are numerous
vertebrate long-chain acyl-CoA synthetase (ACSL) enzymes,Developmeeach with differences in binding affinity for free long-chain FAs,
tissue expression, and/or subcellular localization (Coleman
et al., 2000). ACSL4 is unique among the characterized acyl-
CoA synthetase enzymes in that it has a strong preference for
AA and EPA over other long-chain FAs (Cao et al., 1998; Kang
et al., 1997; Stinnett et al., 2007).
Mutations in ACSL4 homologs implicate fundamental roles in
cell function and embryonic development. Human mutations
cause X-linked mental retardation and heterozygous female
carriers have extremely skewed X-inactivation, indicating a
survival advantage for cells expressing the wild-type allele
(Longo et al., 2003; Meloni et al., 2002b; Raynaud et al., 2000;
Yonath et al., 2011). Likewise, heterozygous female mice display
compromised uterus development and fertility and only very
rarely transmit the disrupted allele to offspring (Cho et al.,
2001). Finally, Drosophila mutants are recessive lethal (McQuil-
ton et al., 2012) and hypomorphs display defects in segmenta-
tion (Zhang et al., 2011) and development of the central nervous
system (CNS) (Gazou et al., 2013; Liu et al., 2011; Meloni et al.,
2002a, 2009; Piccini et al., 1998; Zhang et al., 2009). However,
the molecular underpinnings of these phenotypes have yet to
be described.
In this report, we demonstrate a requirement for Acsl4a in
dorsoventral patterning of the zebrafish embryo and elucidate
the molecular mechanisms underlying this effect. The vertebrate
dorsoventral axis is patterned by a gradient of bone morphoge-
netic proteins (Bmp), members of the transforming growth factor
b (TGF-b) superfamily of secreted growth factors. Bmps bind
transmembrane type I/type II serine/threonine kinase receptor
complexes, which phosphorylate serine residues at the C termi-
nus of receptor-regulated Smad transcription factors (R-Smad;
Smad1,5,8). R-Smads are the intracellular proteins that trans-
duce the extracellular Bmp signal to the nucleus and regulate
gene transcription (Macı´as-Silva et al., 1996).
In zebrafish, the ventral-to-dorsal Bmp gradient is set up
stepwise. Zygotic bmp2b and bmp7a expression is initiated by
the maternally supplied Bmp member Gdf6a (Sidi et al., 2003;
Wilm and Solnica-Krezel, 2003) and mediated by maternally
and zygotically supplied Smad5 (Hild et al., 1999; Kramer
et al., 2002), followed by a refinement of the gradient involvingntal Cell 27, 635–647, December 23, 2013 ª2013 Elsevier Inc. 635
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midt et al., 1996b; Kishimoto et al., 1997; Nguyen et al., 1998)
and by the dorsal secretion of Bmp inhibitors (reviewed in De
Robertis and Kuroda, 2004; Hammerschmidt and Mullins,
2002; Little and Mullins, 2006; Schier and Talbot, 2005).
Whereas this linear Bmp signaling pathway has been well
described, recent studies suggest that R-Smads can integrate
inputs from other signaling pathways known to profoundly influ-
ence embryogenesis. For example, fibroblast growth factor
(FGF) and Wnt signaling modulate R-Smad activity by regulating
phosphorylation of a central linker region of the R-Smad protein
(Fuentealba et al., 2007; Sapkota et al., 2007). FGF signals via a
mitogen-activated protein kinase (MAPK), which phosphorylates
four conserved consensus sites (PXSP; Kretzschmar et al., 1997;
Sapkota et al., 2007). Canonical Wnt signaling acts via inhibition
of glycogen synthase kinase 3 (GSK3; He et al., 1995), which
phosphorylates R-Smad after it has been primed by MAPK
phosphorylation (Fuentealba et al., 2007; Sapkota et al., 2007).
Together, MAPK and GSK3 phosphorylation of R-Smad leads
to binding of Smad ubiquitin regulatory factor (Smurf) E3 ubiqui-
tin ligases, polyubiquitination, and proteasomal degradation,
thus turning off Bmp signaling (Fuentealba et al., 2007; Sapkota
et al., 2007; Zhu et al., 1999).
In the present study, we demonstrate that Acsl4a regulates
Bmp R-Smad activity and thus is essential for dorsoventral
patterning. Disruption of Acsl4a induces a dorsalized phenotype,
resulting from its unexpected role in maintaining proper levels
of activated R-Smad transcription factors. We unravel the
molecular mechanism underlying this effect, demonstrating
that Acsl4a is required to inhibit p38 MAPK and Akt-dependent
GSK3 activity, thereby attenuating R-Smad linker phosphory-
lation and promoting R-Smad stability. Our data implicate
LC-PUFA metabolism in R-Smad regulation and vertebrate
dorsoventral patterning.
RESULTS
Identification of Zebrafish ACSL4 Orthologs
To search for ACSL4 orthologs, we queried the zebrafish
genome assembly with the human ACSL4 protein sequence,
revealing two genes, acsl4a and acsl4-like (acsl4l). We confirmed
that these genes are orthologous to themammalian ACSL4 gene
based on synteny (Figure S1A available online) and protein
sequence homology (Figure S1B). Zebrafish Acsl4a best
matches the characterized ACSL4 proteins (Figures S1B–S1D).
A residue important for AA activation (Stinnett et al., 2007) is
conserved in Acsl4a and lost in Acsl4l (Figure S1C). Furthermore,
Acsl4a contains the N-terminal region of the brain-specific hu-
man ACSL4 splice isoform (Meloni et al., 2002a; Figure S1D).
Consistent with our hypothesis that LC-PUFA metabolism is
essential during early embryogenesis, whole-mount mRNA
in situ hybridization revealed maternal acsl4a transcript (Fig-
ure 1A). Zygotic expression initiates at the beginning of gastrula-
tion (germ ring stage, 5.5 hours postfertilization [hpf]; Figure 1A).
During gastrula stages, acsl4a is highly expressed in the yolk syn-
cytial layer (YSL; Figure 1A), an early segregating cell lineage
important for the uptake of yolk nutrients as well as secretion of
signaling molecules (reviewed in Carvalho and Heisenberg,
2010). In addition,acsl4a is expressed in thedevelopingCNS (Fig-636 Developmental Cell 27, 635–647, December 23, 2013 ª2013 Elsure S1E), consistent with the observation that Acsl4a orthologs
impact brain function (Meloni et al., 2002a; Zhang et al., 2009).
Acsl4a Plays a Role in Dorsoventral Patterning
For Acsl4a loss-of-function studies, we designed two transla-
tion-blocking antisense morpholinos (MO) to the 50 untranslated
region (UTR) of the acsl4a transcript. Loss of Acsl4a results in
significant dorsalization of zebrafish embryos (Figures 1B–1H,
S1E–S1I, and S2A–S2D; see Figures S2A–S2D for a comparison
of MO1 and MO2). The morphology of acsl4amorphants resem-
bles that of mutations in ventral-specifying bmp genes (Mullins
et al., 1996); each shows a loss of ventrally derived tissues,
such as blood, pronephros, and tail, and the expansion of dorsal
tissues, such as notochord and somites, resulting in the trunk
twisting upon itself (Figure 1B).
These morphological changes were preceded by correspond-
ing shifts in the expression domains of ventral- and dorsal-
specific genes (Figure 1C) during gastrula (Figures 1D–1G) and
segmentation stages (Figures 1H–1I and S1E–S1H). At midgas-
trula stages (80% epiboly; 8.5 hpf), acsl4a morphants display
strong ventral expansion of the expression domains of tbx6 (Fig-
ures 1D and S2B) in dorsal (paraxial) mesoderm and foxb1.2 (Fig-
ure 1F) in dorsal (neural) ectoderm, both of which extend around
the entire circumference of the embryos and fuse ventrally. In
contrast, expression of eve1, a marker of ventral mesoderm (Fig-
ure 1E) and gata2, a marker of ventral ectoderm (Figure 1G), are
lost in acsl4a morphant embryos. During segmentation stages,
expansion of dorsal derivatives is evident in the neural plate
(increased width of the midbrain-hindbrain boundary and of hind-
brain rhombomeres 3 and 5: Figures 1H, S1E–S1G, and S2A),
somites (Figure1I), andnotochord (FigureS1I). Conversely, ventral
derivatives such as the pronephros (Figure 1H), otic placode (Fig-
ures 1H and S1G), and blood (Figures S2C and S2D) are absent or
strongly reduced.
Overexpression of acsl4a has the opposite effect—ventraliza-
tion, characterized morphologically by a decrease or absence of
the head and notochord and the expansion of the blood island
(Figure 1B; Fisher et al., 1997; Hammerschmidt et al., 1996b).
To confirm that the enzymatic activity of Acsl4a contributes to
the ventralized phenotype, we mutated a conserved amino
acid in zebrafish Acsl4a that was shown to be essential for
catalytic activity of rat ACSL4 (Stinnett et al., 2007). Overexpres-
sion of the catalytically inactive Acsl4a (Acsl4aCI) produced
morphologically wild-type embryos (Figure 1B). In addition, in-
jection of acsl4a mRNA (lacking the 50 UTR targeted by the
MOs) diminished the dorsalized phenotype caused by acsl4a
MO (p < 0.05; Figures S2E and S2F), indicating that the effects
caused by the acsl4a MO and mRNA are specific.
Two lines of evidence suggest that it is the maternally depos-
ited acsl4a mRNA that mediates the effect on dorsoventral
patterning. First, in contrast to the translation-blocking MOs,
three splice-blocking MOs gave no discernible dorsoventral
defects (Figure S2G; data not shown). Translation-blocking
MOs inhibit both maternal and zygotic mRNA (Heasman et al.,
2000; Nasevicius and Ekker, 2000), whereas splice-blocking
MOs do not inhibit maternal mRNA (which is stored as spliced,
mature transcripts). Second, we directly targeted the zygotic
acsl4a transcripts by exploiting their restricted expression in
the YSL. Injecting a translation-blocking MO directly into theevier Inc.
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Figure 1. Acsl4a Is Necessary for Proper Dorsoventral Patterning
(A) acsl4a expression throughout early embryonic development. Whole-mount mRNA in situ hybridizations. Expression pattern was consistent over multiple
experiments (n = 7) and between two separate riboprobes targeting acsl4a. Lateral views, animal pole to the top. e, epiboly.
(B) Morphological defects in dorsoventral patterning caused by perturbation of acsl4a expression. Phenotypic classes were assigned as described elsewhere
(Kishimoto et al., 1997). Representative bright-field images of wild-type embryos (24 hpf) that are dorsalized (class C4 phenotype shown) when injected with
acsl4a MO and ventralized (class V3 phenotype shown) when injected with acsl4a mRNA. Embryos injected with a catalytically inactive version of acsl4a
(acsl4aCI) mRNA and control siblings develop normally. Arrowhead indicates wound-up trunk and arrow indicates expanded blood island. 500 fmol acsl4aMO;
n = 8 experiments (406 embryos); 79%C5, 8%C4, 11%C3, 1%C2, and 1%C1; 1.2–1.5 ng acsl4amRNA; n = 3 (101 embryos); 6%V4, 23%V3, 25%V2, 45%V1, 2%
N; 1.2–1.5 ng acsl4aCI mRNA; n = 3 (123 embryos); 100% N.
(C) Fate map of the gastrula-stage zebrafish embryo (Kimmel et al., 1990; Schier and Talbot, 2005). Blue represents ventral fates and red represents dorsal fates.
(D–G)Whole-mountmRNA in situ hybridization ofmarkers of dorsal and ventral tissues in 80%epiboly stage embryos, either control or acsl4aMO-injected. Animal
pole view,dorsal to the right. (D) tbx6, amarker of dorsal presumptiveparaxialmesoderm, is expandedventrally inacsl4aMO-injectedembryos. 95%of acsl4aMO-
injected (750 fmol) embryosdisplayed expansion>180degrees (n =8; 323embryos). (E)eve1, amarker of ventralmesoderm, is reduced in acsl4aMO-injected (500
fmol) embryos (97%; n = 6; 272 embryos). (F) foxb1.2, a marker of neural plate/dorsal ectoderm, is expanded ventrally in acsl4aMO-injected (500 fmol) embryos
(93%; n = 4; 135 embryos). (G) gata2a, a marker for epidermis/ventral ectoderm, is reduced in acsl4aMO-injected (500 fmol) embryos (98%; n = 4; 181 embryos).
(H) pax2a andmyod1 expression in four-somite stage embryos. Dorsal view, anterior to the left. pax2amarks m/h, midbrain/hindbrain boundary; o, otic placode;
and p, pronephros. myod1 marks a, adaxial cells. 98% of acsl4a MO-injected (500 fmol) embryos had expansion of pax2a marking m/h (n = 7; 125 embryos).
Seventy-five percent of acsl4a MO-injected (500 fmol) embryos had loss and 25% had reduced expression of pax2a marking pronephros (n = 5; 86 embryos).
(I)myod1 expression in 15-somite stage embryos. Dorsal view, anterior to the left. s, somites. Ninety-six percent of acsl4aMO-injected (500 fmol) embryos had
expanded somites (n = 10; 138 embryos).
See also Figures S1 and S2.
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Figure 2. Bmp Expression and Signaling Is Dependent on Acsl4a
(A and B) Whole-mount mRNA in situ hybridization of bmp transcripts in control embryos and embryos injected with acls4a MO (500 fmol) or acsl4a mRNA
(1.25 ng). In acls4a morphants, the ventral-to-dorsal gradient of (A) bmp2b and (B) bmp7a is attenuated (in 87% and 78%, respectively) while acls4a over-
expression enhances bmp expression (in 77% and 75%, respectively). n = 4; 88–119 embryos. Animal pole view, dorsal to the right (30% epiboly).
(C) Western blot of C-terminally phosphorylated Smad1/5/8 (pSmadC-Term) and total Smad1/5/8 (SmadTotal) from shield-stage control embryos and embryos
injected with 750 fmol acsl4a MO (left). Quantification of three (sphere) or five (shield) experiments (right). Data are represented as mean ± SE. *p < 0.05 ***p <
0.001; one sample t test with Bonferroni correction (sphere stage MO = 500 fmol, shield stage MO = 500–750 fmol).
(D) Whole-mount immunostain against pSmadC-Term at 80% epiboly. Staining is reduced in morphants (500 fmol) when compared to control siblings (98%; n = 5;
155 embryos). Animal pole view, dorsal to the right (80% epiboly). Inset is a 23 magnification of the ventral-most region.
(E) Acsl4a is needed in the Bmp ligand-receiving cell for Smad activation. (Left) Schematic of transplantation experiment. (Right) pSmadC-Term immunofluores-
cence in transplanted cells in ventral equatorial regions of host embryos (80%epiboly). Top panel: wild-type cells transplanted intowild-type embryos have normal
pSmadC-Term staining (26/26 embryos, three independent experiments). Middle panel: Morphant cells transplanted into wild-type embryos lack pSmadC-Term
staining, whereas adjacent cells have normal pSmadC-Term staining (16/16 embryos, n = 3). Bottom panel: Wild-type cells transplanted into morphants have
pSmadC-Term staining, whereas adjacent morphant cells lack pSmadC-Term signals (17/17 embryos, n = 3). Wild-type cells transplanted into morphants show
reduced pSmadC-Term staining compared to wild-type cells transplanted into wild-type hosts (compare bottom and top panels). FL, fluorescein dextran.
See also Figure S3.
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contrast to injection into the one- to four-cell stage (Figure S2H).
Acsl4a Alters the Bmp Gradient
The Bmp gradient governing dorsoventral patterning involves
both maternally and zygotically supplied factors (Hammersch-
midt and Mullins, 2002). To assess whether maternally supplied638 Developmental Cell 27, 635–647, December 23, 2013 ª2013 Elsacsl4a is involved in early steps of Bmp gradient formation,
we performed bmp expression analysis at a late-blastula
stage (30% epiboly; 4.5 hpf). Injection of an acsl4a MO disrupts
the ventral-to-dorsal bmp2b and bmp7a gradient, whereas
overexpression of Acsl4a results in elevated and ectopic dorsal
bmp expression (Figures 2A and 2B). During gastrulation
(80% epiboly; 8.5 hpf), when the dorsoventral axis is beingevier Inc.
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sion (1.5- and 1.6-fold, respectively, p < 0.0005; RNA-seq) in
acsl4a MO-injected embryos. Corresponding changes were
observed for C-terminal phosphorylated (activated) Smad1/5/8
(pSmadC-term), a direct readout for Bmp signaling (Tanimoto
et al., 2000). As early as late blastula stages (sphere; 4 hpf),
when pSmadC-term levels in wild-type embryos are relatively
low, there is a significant reduction in acsl4a MO-injected em-
bryos (Figures 2C and S3A). At shield stage (6 hpf), this reduction
is even more pronounced (Figures 2C and S3B). Moreover,
immunohistochemistry reveals a lack of pSmadC-term in the
ventral nuclei of acsl4a morphants (Figure 2D). In contrast to an
almost complete loss of pSmadC-Term, total Smad1/5/8 levels
are only partially reduced in shield stage acsl4a morphants (Fig-
ures 2C, S3A, and S3B). Together, these data indicate that the
dorsalization of acsl4a morphants is due to a reduction in the
Bmp gradient and diminished Bmp signaling.
Acsl4a Plays a Role in Bmp Signal Reception/
Transduction
The early alterations in bmp expression observed in acsl4a
morphants are similar to those previously reported for embryos
lacking maternal supply of the TGF-b ligand Radar/Gdf6a (Sidi
et al., 2003) or maternal supply of Smad5 (Kramer et al., 2002).
Furthermore, Bmps exhibit positive feedback on the transcrip-
tion of their own genes (e.g., Kishimoto et al., 1997; Nguyen
et al., 1998). Therefore, the reduced bmp expression levels
observed in acsl4a morphants could result either from attenu-
ated levels of Bmp ligands or an impaired ability to respond to
Bmp. To help distinguish between these two possibilities, we
performed cell transplantation experiments (Figure 2E). Upon
transplantation into wild-type hosts, acsl4a morphant cells lack
pSmadC-term staining, whereas directly adjacent wild-type cells
show normal levels (Figure 2E, middle panel). Bmps have been
shown to act both in an autocrine (Nikaido et al., 1999) and a
paracrine fashion (Kishimoto et al., 1997; Nguyen et al., 1998),
with cells receiving Bmp ligand that is secreted both by them-
selves and by adjacent cells. Therefore, we conclude that
isolated ascl4amorphant cells are incapable of processing para-
crine Bmp signals from their wild-type neighbors, indicative of a
role for Ascl4a at the level of Bmp signal reception or transduc-
tion. Conversely, wild-type cells transplanted into acsl4a MO-
injected hosts are positive for pSmadC-term staining, whereas
morphant neighbors are not (Figure 2E, bottom panel). While
these data illustrate that wild-type cells are capable of process-
ing Bmp signals in an Acsl4a-depleted environment, normalized
pSmadC-term staining intensities are reduced to 51.9% ± 7.5% of
the intensities of wild-type cells transplanted into wild-type hosts
(p < 0.0005; compare top and bottom panels of Figure 2E). This
effect is most likely due to reduced bmp expression in acsl4a
morphant host cells, thus resulting in compromised paracrine
Bmp signaling to the transplanted wild-type cells. In sum, the re-
sults of the transplant studies suggest a role for Ascl4a in Bmp
signal reception and/or transduction.
Acsl4a Acts Downstream of Bmp Receptor Activation to
Regulate R-Smad Activity
To study whether Acsl4a interferes with Bmp signal transduction
at the level of receptor activation, we tested the effects of aDevelopmeconstitutively active (CA) version of the type I receptor, Alk8
(Alk8 Q204D; Bauer et al., 2001) on the acsl4a morphant
phenotype. Type I receptors bearing this modification activate
signal transduction and phosphorylate R-Smad proteins in the
absence of Bmp ligands (Wieser et al., 1995). To quantify the
extent of dorsalization, we measured the angle of dorsal
mesodermal marker tbx6 expression in late gastrulae (described
in Figure 3A). acsl4a MO-injected embryos have a significantly
(p < 0.0001) expanded angle of tbx6 expression (Figures
3B and 3C). Combining Acsl4a depletion with Alk8CA overex-
pression resulted in similarly dorsalized embryos (Figures 3B
and 3C). We obtained comparable results when we assessed
dorsoventral patterning by morphological criteria at later devel-
opmental stages (24 hpf; Figure S4); in contrast to loss of Acsl4a,
the loss of Bmp2b was efficiently rescued by alk8CA mRNA.
Furthermore, western blots at sphere (Figure 3D) and at shield
stage (Figure 3E) revealed a robust increase of pSmadC-Term
levels after injection of alk8CA mRNA (second lane). However,
there is little to no pSmadC-Term immunoreactivity in acsl4amor-
phants overexpressing Alk8CA (fourth lane). Collectively, our
findings indicate a role for Acsl4a in regulating the intracellular
Bmp signaling cascade, downstream of type I receptors.
Acsl4a Mediates Its Effect on R-Smad Activity via Linker
Phosphorylation
R-Smads are both positively and negatively regulated by phos-
phorylation events (Figure 4A). R-Smads are activated by Bmp
receptor-mediated phosphorylation (Macı´as-Silva et al., 1996),
whereas linker phosphorylation by MAPKs and GSK3 leads to
proteasomal degradation (Fuentealba et al., 2007; Sapkota
et al., 2007; Zhu et al., 1999). Thus, the loss of pSmadC-term in
acsl4a morphants may be due to (1) failure of Bmp receptor-
mediated phosphorylation or (2) degradation following linker
phosphorylation. To distinguish between these two possi-
bilities, we asked whether either bypassing Bmp receptor-
mediated phosphorylation or preventing linker phosphorylation
of R-Smad could rescue the acsl4a morphant phenotype.
To bypass Bmp receptor-mediated phosphorylation, we utilized
a constitutively active, phosphomimetic Smad5 (Smad5PM),
in which the C-terminal serine targets of the Bmp receptor
(SSVS) are replaced with aspartate residues. To abolish
linker phosphorylation, we generated a MAPK-resistant Smad5
(Smad5DMAPK) by mutating the serine residues of the four
MAPK target sequences to alanines (PXSP/PXAP; Figures 4A
and S5A).
Overexpression of Smad5 (Figure S5C) or Smad5PM (Figures
4B and 4C) fails to rescue the acsl4a morphant’s dorsalized
phenotype, although they are slightly less dorsalized than acsl4a
MO alone. This is in striking contrast to the effects of MAPK-
resistant Smad5 (Figures 4B and 4C). When combined with
acsl4a MO, smad5DMAPK mRNA not only rescues the dorsalized
phenotype of acsl4a MO, it results in ventralization (Figures 4B
and 4C). Importantly, this outcome is not due to smad5DMAPK
having a stronger ventralizing ability than smad5PM, as we
confirmed that the mRNAs had comparable ventralizing effects
with parallel injections into wild-type controls (Figures S5D and
S5E). This shows that the R-Smad linker phosphoresidues
are essential for the dorsalized phenotype of acsl4a morphants.
To confirm that the loss of Smad signaling is due to linkerntal Cell 27, 635–647, December 23, 2013 ª2013 Elsevier Inc. 639
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Figure 3. Acsl4a Acts Downstream of Bmp Receptor Activation
(A) The extent of dorsalization is measured by adding the angles of the arcs of
dorsal marker tbx6 expression on either side of the tbx6 negative midline at
80% epiboly. Embryos are considered completely dorsalized if the arcs meet
on the ventral side.
(B and C) Constitutively active Bmp receptor does not rescue the phenotype
caused by acsl4a depletion. (B) tbx6 expression in a control embryo, embryo
injected with acsl4a MO alone (750 fmol), or acsl4a MO combined with
constitutively active alk8 (alk8CA, 1.5 ng) mRNA. Vegetal pole view, dorsal to
the right (80% epiboly). (C) Quantification of tbx6 expression domain. Data are
represented as mean of experimental means ± pooled SE (n = 3–8; 12–80
embryos/experiment). ANOVA with Dunnett post hoc test; ***p < 0.0001,
compared to control.
(D and E) Western blots (n = 3) of C-terminally phosphorylated Smad1/5/8
(pSmadC-Term) from embryos injected with alk8CA mRNA (20-40 pg), acsl4a
MO (500 fmol), or acsl4a MO and alk8CA mRNA combined. Anti-BAP/MAK32
is the loading control. (D) Lysates from sphere-stage embryos. (E) Lysates from
shield-stage embryos. An extraneous lane between control and alk8CA is
omitted.
See also Figure S4.
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tion of R-Smad, we examined C-terminal phosphorylation of
Smad5DMAPK and a degradation-resistant Smad5 lacking the
Smurf binding site (Figure S5B; Smad5DSmurf). Both constructs
are phosphorylated by the Bmp receptor in an Acsl4a-indepen-
dent manner (Figure S5F). Together, these data support a model
where Acsl4a promotes Bmp signal transduction by inhibiting
R-Smad linker phosphorylation and consequently proteasomal
degradation.
Acsl4a Regulates p38 MAPK Activity and Smad1/5
Linker Phosphorylation
There are three major MAPK family members, extracellular
signal-regulated kinases (Erk), c-Jun N-terminal kinases (JNK),
and p38 kinases, all of which have been shown to be capable
of phosphorylating and inhibiting Bmp R-Smads (Fuentealba
et al., 2007; Kamaraju and Roberts, 2005; Mori et al., 2004). To
investigate whether Acsl4a affects MAPK activity, we utilized
phosphospecific antibodies to assess levels of activated
MAPK (Figure 5A) or the upstream MAPKK. Indeed, we found
a significant increase in activated p38 MAPK levels in acsl4a
MO-injected embryos (4 ± 0.9-fold, p < 0.01, n = 6; Figure 5B)
between high and sphere stages (3.5–4 hpf). In contrast, levels
of activated Erk1/2 and MKK4, the MAPKK upstream of JNK,
are not increased in acsl4a MO-injected embryos (Figures S6A
and S6B).
In order to determine if activation of p38 MAPK results in the
phosphorylation of the R-Smad linker, we utilized an antibody
created to recognize MAPK phosphorylated R-Smad (Fuen-
tealba et al., 2007). Endogenous levels of MAPK phosphorylated
R-Smad could not be detected from zebrafish embryo lysates
(Figure S6C), presumably because Smad1/5 is rapidly ubiquiti-
nated by Smurf E3 ligases (Zhu et al., 1999) and degraded
following linker phosphorylation (Figure 4A). Hence, in order
to stabilize R-Smad, we utilized the aforementioned Smad5
construct lacking the Smurf binding site (PPPAY; Figure S5B).
Using this stabilized Smad5DSmurf, we visualized a marked in-
crease in MAPK phosphorylation in acsl4a morphants (9.7 ±
4.5-fold increase over Smad5DSmurf alone, p < 0.05, n = 5; Fig-
ure 5D). This indicates that during normal development, Acsl4aevier Inc.
ACB
Figure 4. Acsl4a Acts via R-Smad Phos-
phorylation at MAPK Consensus Sites
(A) Model of R-Smad regulation by phosphoryla-
tion. (Top) The Bmp receptor positively regulates
(green) R-Smad activity by phosphorylating the
C terminus. Negative regulation (red) of R-Smad
occurs in sequential steps: (1) MAPK phosphory-
lates the R-Smad linker. (2) GSK3 phosphorylates
the linker upstream of MAPK phosphoresidues. (3)
Smurf1/2 E3 ubiquitin ligase recognizes R-Smad
after phosphorylation by MAPK and/or GSK3.
(4) Smurf1/2 polyubiquitinates R-Smad, leading to
its proteasomal degradation. (Bottom) Sequence
alignment of zebrafish Smad1 and Smad5 linker
regions with important residues highlighted.
(B) tbx6 expression in a control embryo, embryo
injected with acsl4a MO alone (750 fmol), acsl4a
MO combined with a C-terminal phosphomimic
smad5 mRNA (smad5PM; 1.5 ng), and acsl4a
MO combined with a MAPK-insensitive version of
smad5 mRNA (smad5DMAPK; 1.5 ng). Vegetal pole
view, dorsal to the right (80% epiboly).
(C) Quantification of tbx6 expression domain. Data
are represented as mean of experimental means ±
pooled SE (n = 3–8, 12–80 embryos/experiment).
ANOVA with Dunnett post hoc test; *p < 0.01,
**p% 0.005, *** p < 0.0001; compared to control.
See also Figure S5.
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phorylation of Smad1/5.
Acsl4a Regulates Akt and GSK3 Activity, and
Constitutively Active Akt Rescues the Dorsoventral
Defects of acsl4a Morphant Embryos
Linker-mediated degradation of Bmp R-Smad involves sequen-
tial phosphorylation by MAPK and GSK3 (Fuentealba et al.,
2007; Sapkota et al., 2007; Figure 4A). Therefore, we next asked
whether loss of Acsl4a also affects the activity of GSK3. GSK3 is
regulated by multiple means, including inhibitory phosphory-
lation by Akt (also called protein kinase B; PKB) at Ser21
(GSK3a) and Ser9 (GSK3b; Cross et al., 1995; Medina and Wan-
dosell, 2011). Western blot analysis with a phosphospecific
antibody against Ser21/9 phosphorylated GSK3 (Figure 6A)
revealed a strong decrease in inhibitory GSK3 phosphorylation
in shield stage (6 hpf) acsl4a morphants compared to controls,
whereas total GSK3b levels remained unaltered (Figures 6B
and 6E). In addition, Akt activity is significantly reduced in acsl4a
morphant embryos (Figures 6D and 6E).
To investigate whether these alterations in Akt/GSK3 activity
are relevant to Acsl4a’s role in dorsoventral patterning, we
utilized a constitutively active form of Akt (AktCA; Kohn et al.,
1996). Notably, injection of aktCA mRNA leads to increased
GSK3 inhibition in acsl4a morphants (Figure 6F), whereas
reducing the acsl4aMO-induced expansion of dorsal mesoderm
to wild-type conditions (Figures 6G and 6H). This indicates that
in addition to inhibiting p38, Acsl4a promotes the phosphoryla-
tion and activation of Akt, thereby decreasing GSK3 activity.
Moreover, AktCA can compensate for the loss of Acsl4a toDevelopmerestore GSK3 inhibition, Bmp signaling and proper dorsoventral
patterning.
DISCUSSION
Recently, researchers uncovered that during dorsoventral axis
patterning, the Bmp signaling pathway is integrated with other
classical signaling pathways at the level of the R-Smad tran-
scription factors (Fuentealba et al., 2007; Eivers et al., 2008,
2009; Hashiguchi and Mullins, 2013). FGF and Wnt signaling,
which are also implicated in dorsoventral patterning of the
zebrafish embryo (Fu¨rthauer et al., 2004; Lekven et al., 2001),
regulate kinases (MAPK and GSK3, respectively) that phosphor-
ylate Bmp R-Smads on a central linker region, ultimately leading
to degradation through the ubiquitin/proteasome system. We
have found that Acsl4a, an LC-PUFA activating enzyme, is
essential for proper patterning of the zebrafish dorsoventral
axis through its ability to suppress inhibitory linker phosphoryla-
tion of R-Smads by mechanisms that likely act in parallel to FGF
and Wnt signaling (Figure 7).
We provide evidence that Acsl4a influences both the estab-
lishment and zygotic refinement of the Bmp gradient through
its impact on R-Smad transcription factors. Like the Bmp
receptor, Alk8 (Mintzer et al., 2001); the Bmp-related ligand,
Gdf6a (Sidi et al., 2003); and the transcription factor, Smad5
(Hild et al., 1999; Kramer et al., 2002), acsl4a transcripts are
maternally provided. Loss of Acsl4a results in a dramatic reduc-
tion of active R-Smad proteins capable of mediating Bmp signal
transduction. Furthermore, this reduction occurs prior to the
defects caused by loss of Bmp2b and Bmp7a ligands. Thesental Cell 27, 635–647, December 23, 2013 ª2013 Elsevier Inc. 641
Figure 5. Acsl4a Regulates p38 MAPK Activity and R-Smad Linker
Phosphorylation
(A) An acsl4a MO-dependent increase in MAPK activity would result in
phosphorylation of R-Smad and recruitment of Smurf ubiquitin ligase. An
increase in MAPK activity can be assayed by antibodies specific to activated
MAPK.
(B) p38 MAPK activity is upregulated in acsl4a morphants (750 fmol) at high
stage. Western blot for phosphorylated (Thr180/Tyr182) p38 MAPK (active-p38
MAPK; n = 6).
(C) Smad5DSmurf lacks the WW domain-binding box (PPPAY/DDDDD)
recognized by Smurf E3 ubiquitin ligase, thus it is prevented from linker-
mediated degradation. An increase in MAPK phosphorylation of R-Smad can
be assayed with a phosphospecific antibody, pSmadMAPK.
(D) Smad5DSmurf is phosphorylated at the MAPK consensus site (Ser215)
after acsl4a knockdown. Western blot for MAPK phosphorylated Smad
(pSmadMAPK; gift of de Robertis) at sphere stage. acsl4a MO injection
(750 fmol) results in increased pSmadMAPK staining. Alpha tubulin is the loading
control.
See also Figure S6.
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maternally supplied signals like Gdf6a (Sidi et al., 2003) to set
up the early Bmp2b/Bmp7a gradient. Acsl4a may also interfere
with the zygotic refinement of the Bmp gradient, involving pos-642 Developmental Cell 27, 635–647, December 23, 2013 ª2013 Elsitive Bmp2b/Bmp7a autoregulation. Our transplant studies
point to a cell autonomous role for Acsl4a in maintaining the
signaling pool of R-Smad proteins, which is in contrast to
the non-cell-autonomous effect previously described for the
Bmp2b ligand (Nguyen et al., 1998). Furthermore, a constitu-
tively active version of the type I receptor Alk8, which readily
ventralizes bmp2b morphants, fails to do so in acsl4a mor-
phants. Together, these data indicate that Acsl4a must interfere
with intracellular Bmp signal transduction at the level of R-Smad
activity.
We provide several lines of evidence that Acsl4a attenuation
results in the loss of activated R-Smad due to linker-mediated
degradation. We show that in contrast to constitutively active
Smad5 (Smad5PM), overexpression of Smad proteins that lack
the MAPK consensus phosphorylation sites (Smad5DMAPK) or
the binding site for the E3 ubiquitin ligase (Smad5DSmurf) can
rescue the levels of pSmadC-Term and revert the dorsoventral
patterning defects of the acsl4a morphants. In addition, using
the SmadDSmurf construct, we revealed a dramatic increase in
MAPK-mediated R-Smad linker phosphorylation in acsl4a
MO-injected embryos. Total R-Smad levels were significantly
decreased only at later/gastrula stages, which may reflect both
degradation of signaling pools of R-Smad as well as a decrease
in zygotic Smad expression. Indeed, smad1 and smad8/smad9
mRNA levels are significantly decreased in acsl4a morphant
embryos at 80% epiboly (1.24- and 1.58-fold, respectively p <
0.0005; RNA-seq).
Of the threemajor MAPK family members (p38, Erk1/2, MKK4/
JNK), each implicated in dorsoventral patterning (Bradham and
McClay, 2006; Fu¨rthauer et al., 2004; Keren et al., 2008; Pera
et al., 2003; Rui et al., 2007), only activated p38 levels were
significantly increased in acsl4a morphants. This increase
occurred at high stage, consistent with the timing of Smad5
linker phosphorylation and the reduction of both pSmadC-Term
and bmp expression levels in acsl4a morphants. Although p38
MAPK family members have been implicated mainly in nonca-
nonical Bmp/TGF-b signaling and TGF-b R-Smad inhibition
(reviewed in Kamato et al., 2013; Zhang, 2009), they also have
a role in the dorsoventral patterning of Xenopus mesoderm
(Keren et al., 2008).
GSK3 activity can be regulated at multiple levels. Signaling by
canonical Wnts leads to GSK3 inhibition via the modulation of
GSK3/axin/APC/Dishevelled multiprotein complexes. Another
pathway involves Akt/PKB, which inhibits GSK3 via phosphory-
lation at Ser21/9 (Medina and Wandosell, 2011). At shield stage,
when Bmp patterns the dorsoventral axis, acsl4amorphants dis-
played significant reductions both in phosphorylated (active) Akt
and in Ser21/9-phosphorylated (inactive) GSK3 levels. However,
these changes were not evident at sphere stage (data not
shown), when we saw strong p38 MAPK activation.
Our data demonstrating that a constitutively active version of
Akt (Kohn et al., 1996) can rescue the acsl4a morphant pheno-
type further supports a model whereby both p38 MAPK and
Akt/GSK3 work downstream of Acsl4a to regulate R-Smad
stability. For the three kinases to act in a single linear pathway,
p38 would need to activate GSK3 or inhibit Akt. However,
studies have shown that p38 inhibits GSK3 (e.g., Thornton
et al., 2008) or activates Akt (e.g., Perdiguero et al., 2011). There-
fore, and in light of the temporal differences between the changeevier Inc.
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Figure 6. Acsl4a Regulates GSK3 Activity
(A) An acsl4aMO-dependent increase in GSK3 activity would result in phosphorylation of R-Smad and recruitment of Smurf ubiquitin ligase. There are inhibitory
phosphorylation sites (GSK3a Ser21/GSK3b Ser9) that control GSK3 activity level, thus an antibody that recognizes the inhibitory phosphorylation (inactive GSK3)
can assay GSK3 activity.
(B) GSK3 activity is increased in acsl4a morphants (500 fmol). (Left) Western blot for inhibitory phosphorylation (GSK3a Ser21/GSK3b Ser9) of GSK3 (inactive
GSK3). (Right) Western blot for total GSK3b. BAP/MAK32 is the loading control.
(C) GSK3 is inhibited by Akt. An acsl4aMO-dependent decrease in Akt activity would result in decreased inhibition (thus activation) of GSK3. A decrease in Akt
activity can be assayed by an antibody specific to active (phosphorylated on Ser473) Akt.
(D) Akt activity is decreased in acsl4a morphants (500 fmol). Western blot for phosphorylated (Ser473) Akt (active AKT). BAP/MAK32 is the loading control.
(E) Quantification of blots from (B) and (D). Data are mean ± SE of three to four experiments and represented as percent of control (*p < 0.05 ***p < 0.001; one
sample t test with Bonferroni correction).
(F–H) Constitutively active, myristoylated Akt rescues the acsl4a MO’s dorsalized phenotype. (F) Constitutively active Akt (50–100 pg) decreases GSK3 activity
(increase in inactive GSK3) in acsl4a MO-injected (333 fmol) embryos. Data are represented as mean ± SD (n = 2). (G) Expression of tbx6 in a control embryo,
embryo injected with acsl4a MO alone (333 fmol), embryo injected with constitutively active akt mRNA (50–100 pg; aktCA), and acsl4a MO with aktCA. Vegetal
pole view, dorsal to the right (80% epiboly). (H) Quantification of tbx6 expression domain. Data are represented as mean of experimental means ± pooled SE
(n = 3; 20–24 embryos/experiment). ANOVA with Dunnett; *p < 0.05, ***p < 0.0001.
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Figure 7. Acsl4a Enzyme Activity, Wnt Signaling, and FGF Signaling
Regulate R-Smads via Parallel Pathways
See also Figure S7.
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Acsl4a Regulates Bmp Receptor-Regulated Smadin p38 and Akt activity observed in the acsl4a morphants, we
favor a model where Acsl4a regulates p38 and Akt in parallel
pathways. Inhibition of p38 initiates Smad1/5 stabilization and
this effect is maintained by later Akt-mediated inhibition of
GSK3 activity. While the literature on Akt is extensive, there is
little prior work linking it to dorsoventral patterning.
Our observation linking Acsl4a and R-Smad regulation may be
the basis of the defects observed in Drosophila Acsl mutants
(Zhang et al., 2009, 2011). Intriguingly, the segmentation defects
(Zhang et al., 2011) resemble those of Mad (the Smad1/5 homo-
log) depletion (Eivers et al., 2009). Moreover, Drosophila Mad is
phosphorylated by MAPK and GSK3 in segmental patterns and
this phosphorylation is required for proper segment patterning
(Eivers et al., 2009).
In addition to the Bmp R-Smads (Smad1/5/8), the Activin/
Nodal/TGF-b-regulated Smads (Smad2/3) are inhibited by linker
phosphorylation (Funaba et al., 2002; Kretzschmar et al., 1999).
We did not examine levels of Smad2/3 phosphorylation in acsl4a
morphants. However, we showed that Smad2/3-dependent
Nodal signaling (Jia et al., 2008) is unaffected, evidenced by
the normal expression of the Nodal-dependent mesodermal
marker ntl (Feldman et al., 1998; Gritsman et al., 1999; Fig-
ure S7A). This is consistent with the presence of fewer ideal
MAPK (Gonzalez et al., 1991) and GSK3 (Cohen and Frame,
2001) consensus sequences in the Smad2/3 linker (Figure S7B)
and suggests that Acsl4a only affects the Bmp/Gdf, but not the
Nodal/Activin/TGF-b subgroup of the TGF-b growth factor
superfamily.
Another obvious question raised by our study is how Acsl4a
activity ultimately works to suppress p38 MAPK and to activate
Akt. Whereas ACSL4 orthologs activate LC-PUFAs (the eicosa-
noid precursors), it is unclear whether loss of Acsl4a produces
changes in eicosanoid signaling. Consistent with Acsl4a inhibit-
ing MAPKs, LC-PUFAs and eicosanoid metabolites have been
shown to regulate MAPK activity (Alexander et al., 2001; Denys
et al., 2002; Garcia et al., 2009; Holzer et al., 2011; Rao et al.,
2007; Schley et al., 2007; Xue et al., 2006; Zeyda et al.,
2003); however, the mechanism(s) of MAPK regulation remains
unclear. It was recently reported that membrane FA saturation
levels impact JNK activity through c-Src activation (Holzer
et al., 2011). Saturated FAs activated JNK, while EPA inhibited
JNK activity. Thus, Acsl4a activity could potentially influence644 Developmental Cell 27, 635–647, December 23, 2013 ª2013 Elslevels of membrane phospholipids containing LC-PUFAs, which
in turn alter membrane fluidity. Similarly, there is ample evi-
dence for LC-PUFA and eicosanoid regulation of PI3K and
Akt activity (Couplan et al., 2009; Covey et al., 2007; Hii et al.,
2001). We have embarked on an extensive study to charac-
terize zebrafish lipids during development with the eventual
goal of exploring how specific lipid classes may change after
Acsl4a genetic manipulation. These ongoing efforts will hope-
fully point to specific LC-PUFAs or their metabolites that regu-
late p38 and Akt activity, and thus, Bmp signaling. Future
studies are needed to address whether p38 and Akt are
required for dorsoventral patterning of the zebrafish embryo.
Initial studies knocking down one of the six p38 orthologs
(Hsu et al., 2011) and two of the five Akt orthologs (Cheng
et al., 2013; Jensen et al., 2010) report no dorsoventral
patterning defects.
Our study reveals a mechanism by which an LC-PUFA acti-
vating enzyme modulates the Bmp signaling pathway. It is
unlikely that the effect of Acsl4a on Bmp R-Smad activity is
restricted to early dorsoventral patterning. Future studies will
have to demonstrate whether similar mechanisms are at play
during the other various roles of Bmp signaling during develop-
ment and disease (Bandyopadhyay et al., 2013).
EXPERIMENTAL PROCEDURES
Fish Husbandry
Wild-type embryos were obtained from TL/EK, AB, or FWT intercrosses. The
FWT strain was generated from the AB strain outcrossed once to a wild-
type strain from a commercial supplier (to reintroduce hybrid vigor) and inbred
several generations. Embryos were collected from natural spawning and
raised and staged as described (Kimmel et al., 1995). Embryos older than
15 hpf were anesthetized with 0.2% Tricaine before use. Zebrafish care and
experimental procedures were carried out in accordance with the Animal
Care and Use Committees of both the Carnegie Institution and the University
of Cologne.
Whole-Mount In Situ Hybridization
In situ hybridization was performed essentially as described elsewhere (Ham-
merschmidt et al., 1996a; Thisse et al., 1993). See the Supplemental Experi-
mental Procedures for probe information.
Morpholinos and mRNA Synthesis
MOs were purchased from Gene Tools. Unless otherwise stated, acsl4aMO1
was used in experiments. The 50 capped, 30 polyadenylated mRNAs were
synthesized using the mMESSAGE mMACHINE kit (Ambion). For additional
details, see the Supplemental Experimental Procedures.
Phenotypic Analysis
Embryos were assigned a phenotypic class (Dorsalized: C5 most severe to C1
least severe; Ventralized: V4 most severe to V1 least severe; Wild-type: N) as
previously described (Kishimoto et al., 1997).
Whole-Mount Immunohistochemistry
Whole-mount immunohistochemistry was performed essentially as described
elsewhere (Hammerschmidt et al., 1996b). For additional details, see the Sup-
plemental Experimental Procedures.
Transplantation Studies
Donor embryos were injected at the one- to four-cell-stage with fluorescent
lineage tracer fluorescein dextran (1 mg/ml). Donor cells were transplanted
into recipient embryos until high stage (3.5 hpf). Embryos were fixed at 80%
epiboly and immunofluorescence analyses were performed. Host embryos
with one or, at maximum, two adjacent GFP-positive cells at the ventralevier Inc.
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quantification, see the Supplemental Experimental Procedures.
Western Blots
Western blots and their subsequent quantification were performed by stan-
dard procedures (see the Supplemental Experimental Procedures).
Statistics
Bartlett’s test was performed on all data to examine scedasticity prior to
further statistical analysis. An unpaired Student’s t test was performed to
compare normalized pSmadC-Term signal intensities of transplant data.
ANOVA followed by the Dunnett post hoc test was performed on the Bmp
signaling pathway epistasis data (Figures 2, 4, and S5) and constitutively active
Akt rescue data (Figure 6H). ANOVA with the REGWQ post hoc test was
carried out to evaluate the acsl4a mRNA rescue of the acsl4a MO phenotype
(Figure S2F). For western blot analysis, one-sample t tests were performed
on data normalized to control lysates (and for experiments with multiple com-
parisons, a Bonferroni correction factor was applied).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.devcel.2013.11.011.
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